Kamat - Figure 15
BCG Maintenance: Not Created Equal
References
Kamat AM, Porten S. Myths and mysteries surrounding bacillus Calmette-Guérin therapy for bladder cancer. Eur Urol. 2014;65:267−9 http://dx.doi.org/10.1016/j.eururo.2013.10.016
Lamm DL, Blumenstein BA, Crissman JD, et al. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. J Urol. 2000;163:1124−9 http://dx.doi.org/10.1016/S0022-5347(05)67707-5
Hudson MA, Ratliff TL, Gillen DP, et al. Single course versus maintenance bacillus Calmette-Guerin therapy for superficial bladder tumors: a prospective, randomized trial. J Urol. 1987;138:295−8 https://doi.org/10.1016/S0022-5347(17)43125-9
Badalament RA, Herr HW, Wong GY, et al. A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer. J Clin Oncol. 1987; 5:4419 https://doi.org/10.1200/JCO.1987.5.3.441
Palou J, Laguna P, Millán-Rodríguez F, et al. Control group and maintenance treatment with bacillus Calmette-Guerin for carcinoma in situ and/or high grade bladder tumors. J Urol. 2001;165:1488−91 http://dx.doi.org/10.1016/S0022-5347(05)66333-1
